Bayer's Kerendia reduced the risk of cardio death by 16% in tough-to-treat class of heart failure patients
1st September 2024 Uncategorised 0Bayer’s Kerendia reduced the risk of cardio death by 16% in tough-to-treat class of heart failure patients kdunleavy Sun, 09/01/2024 – 09:35 More: Bayer's Kerendia reduced the risk of cardio death by 16% in tough-to-treat class of heart failure patients
read more